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Treating the aborted fetus as a human
cadaver is believed to be justified because it is
respectful and protective of the fetus. In the
United States, most states permit the donation
and procurement of human fetal tissue for edu-
cational, research, or therapeutic purposes in
accord with the Uniform Anatomical Gift Act
(UAGA). These state laws specify the protec-
tions necessary for the fetal cadaver and the
circumstances under which the next-of-kin may
donate its remains. However, treating the
woman who agrees to donate fetal tissue merely
as one of the next-of-kin who may consent to
donate the tissue of her deceased relative is dis-
respectful and leaves her vulnerable to harm. It
overlooks both the risks that donating fetal
tissue pose to her as well as the unique relation-
ship that exists between a woman and a fetus.
The cadaver donor framework, for example,
does not require the woman’s consent before
fetal tissue may be used; the consent of the
father is considered sufficient. And, in any case,
only minimal information is required to be dis-
closed to those deciding whether to donate the
tissue of a deceased relative.
The following are possible risks to a woman’s
privacy and well-being associated with donating
tissue for transplantation after elective abortion:
Her blood may be tested for infectious agents
such as HIV.
The tissue may be labeled with an identifier
that makes it possible to trace the woman
who had the abortion and donated the tissue.
Persons uninvolved in the woman’s care may
have access to her clinic records to obtain
information about her medical history.
The abortion procedure may be modified in
ways that prolong or intensify discomfort, or
that increase the risks of physical harm to the
woman.
The living organ donor framework is more
respectful and protective of the woman who is
asked to donate fetal tissue than the cadaver
donor framework. It acknowledges that the
woman has a unique and privileged relationship
with the fetus and that donation poses a variety
of significant risks to the woman. Her respect
and protection should be secured in the follow-
ing ways:
Her consent should be necessary; the father’s
consent should never be sufficient.
She should be informed of the proposed use
of the tissue.
She should be informed of the risks that
donation poses to her privacy. She should be
informed of the risks associated with testing
her blood or urine to establish the quality of
the tissue, labeling the fetal tissue with an
identifier traceable to her, and tissue
procurers or others not directly involved in
her care gaining access to private information
in her clinic record.
She should be informed of any modifications
of the abortion procedure and the associated
risks to her well-being. She should be
informed of the risks of prolonged or intensi-
fied discomfort as well as the risks of
incomplete abortion or trauma to the cervix
associated with any modifications, e.g., slow-
ing the abortion procedure, decreasing the
pressure of the suction, or increasing the
dilatation of the cervix and the cannula.
Neither the cadaver donor framework, nor
the living organ donor framework, by itself cap-
tures the full range of obligations to both the
fetus and the woman involved in fetal tissue
transplantation. Combining these frameworks,
however, so that they complement and con-
strain, rather than conflict with one another, will
ensure that both the woman and the fetus are
protected and respected.
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